I'm hearing you Robert76.. But Sharad Joshi himself has just...

I'm hearing you Robert76..
But Sharad Joshi himself has just said that "Work with Sensera continues".

From the email by Ralph Schimdt.
"To say this is a straightforward wafer is ridiculous. This is a highly sophisticated unique structure with days of processing with unique materials that when combined form the sensor. It took 18 months to develop with many PHD level people at the customer and Sensera to make operational."

Maybe how complicated the Sensera/NanoDx sensor is, requiring "days of processing" is seen as a potential problem in producing the 10s of millions of devices, that they see demand for?

The IBM-designed nano biosensors are metal-oxide semi-conductive (CMOS)-compatible, which means they may be more cost-effectively and rapidly manufactured in high-volume. When integrated with automation circuitry, these tiny sensors may enable NanoDx’s real-time, point-of-care diagnostics technology to detect and quantify biomarkers from small fluid specimens in less than two minutes.

IBM has licensed its nanosensor technology to NanoDx without warrantee of success for it to solely develop a diagnostic product.

The official wording from IBM is not conclusive that their sensors with the NanoDx device will work.

We know the device works with the Sensera/NanoDx device, but are they trying to find a cheaper, more easily mass produced sensor, that does the same job?..
Why wouldn't they?

There has been no release from Sensera that we are out of the loop.
But they wouldn't be required to announce that NanoDx is trying to find an alternative.

Is this why they still haven't got FDA EUA, because they are still messing with componentry?

The fact that they had been involved with IBM to some extent all this time and approached them at the Pivot point of TBI to Covid19 detection, suggests that they and we, were always part of the equation.

We can't expect any sort of a reply or confirmation from Sensera, as they have no control over what NanoDx do.

The most we can do, if replacing our part of the equation is in question, is to hope that IBM's simpler sensor is not as accurate or effective!

There's more twists here than an Agatha Christie's novel!